|
OMIM |
Link |
Information gain |
01 |
|
glomerulopathy with fibronectin deposits
|
[NCBI]
|
0.00256772
|
|
|
MCKD1
|
[NCBI]
|
0.00244368
|
|
|
urogenital adysplasia, hereditary
|
[NCBI]
|
0.00224672
|
|
|
osteolysis, hereditary, of carpal bones with nephropathy
|
[NCBI]
|
0.00200785
|
|
|
alport syndrome, autosomal dominant
|
[NCBI]
|
0.00173501
|
|
|
FMF
|
[NCBI]
|
0.00139438
|
|
|
ATD1
|
[NCBI]
|
0.00136736
|
|
|
LPG
|
[NCBI]
|
0.00127591
|
|
|
hypokalemia, familial
|
[NCBI]
|
0.00121753
|
|
|
HNFJ
|
[NCBI]
|
0.00116552
|
|
|
IGAN1
|
[NCBI]
|
0.00100352
|
|
|
SLSN1
|
[NCBI]
|
0.000976629
|
|
|
fatty metamorphosis of viscera
|
[NCBI]
|
0.000949381
|
|
|
SLE
|
[NCBI]
|
0.000907295
|
|
|
oculorenocerebellar syndrome
|
[NCBI]
|
0.00082429
|
|
|
lobular glomerulopathy, familial
|
[NCBI]
|
0.000607155
|
|
|
VUR1
|
[NCBI]
|
0.000574699
|
|
|
NPHP1
|
[NCBI]
|
0.000574097
|
|
|
CF
|
[NCBI]
|
0.000547536
|
|
|
amyloidosis, familial visceral
|
[NCBI]
|
0.000489956
|
|
|
cryoglobulinemia, familial mixed
|
[NCBI]
|
0.000473112
|
|
|
NPS
|
[NCBI]
|
0.000462217
|
|
|
USH2B
|
[NCBI]
|
0.000434211
|
|
|
PTH
|
[NCBI]
|
0.000408882
|
|
|
CAT
|
[NCBI]
|
0.00040184
|
|
|
papillorenal syndrome
|
[NCBI]
|
0.000373233
|
|
|
arima syndrome
|
[NCBI]
|
0.000356164
|
|
|
cataract and cardiomyopathy
|
[NCBI]
|
0.000356164
|
|
|
arthrogryposis, renal dysfunction, and cholestasis
|
[NCBI]
|
0.000319414
|
|
|
fanconi renotubular syndrome
|
[NCBI]
|
0.000305681
|
|
|
bartter syndrome, type 3
|
[NCBI]
|
0.000297247
|
|
|
renal failure, progressive, with hypertension
|
[NCBI]
|
0.000292194
|
|
|
UMOD
|
[NCBI]
|
0.000284919
|
|
|
renal cysts and diabetes syndrome
|
[NCBI]
|
0.000265347
|
|
|
ZS
|
[NCBI]
|
0.000264427
|
|
|
HGF
|
[NCBI]
|
0.000248833
|
|
|
PAX2
|
[NCBI]
|
0.000241555
|
|
|
HNF1B
|
[NCBI]
|
0.000241555
|
|
|
CTNS
|
[NCBI]
|
0.000234542
|
|
|
marden-walker syndrome
|
[NCBI]
|
0.00023111
|
|
|
LYZ
|
[NCBI]
|
0.00022205
|
|
|
danubian endemic familial nephropathy
|
[NCBI]
|
0.000200229
|
|
|
diabetes insipidus, nephrogenic, x-linked
|
[NCBI]
|
0.000191407
|
|
|
renal dysplasia, retinal pigmentary dystrophy, cerebellar ataxia, and skeletal dysplasia
|
[NCBI]
|
0.000188518
|
|
|
fabry disease
|
[NCBI]
|
0.000184917
|
|
|
LCN2
|
[NCBI]
|
0.00018336
|
|
|
hashimoto thyroiditis
|
[NCBI]
|
0.00017852
|
|
|
OCRL
|
[NCBI]
|
0.000177911
|
|
|
HOMG2
|
[NCBI]
|
0.00017576
|
|
|
JBTS1
|
[NCBI]
|
0.000173298
|
|
|
diabetes insipidus, nephrogenic, autosomal
|
[NCBI]
|
0.000170825
|
|
|
CTGF
|
[NCBI]
|
0.000169041
|
|
|
ALB
|
[NCBI]
|
0.000162628
|
|
|
JBTS7
|
[NCBI]
|
0.000161872
|
|
|
CLCN5
|
[NCBI]
|
0.000161162
|
|
|
MPO
|
[NCBI]
|
0.000156303
|
|
|
polycystic kidneys
|
[NCBI]
|
0.00014761
|
|
|
WT1
|
[NCBI]
|
0.00014159
|
|
|
VPS33B
|
[NCBI]
|
0.000141037
|
|
|
proteinuria, low molecular weight, with hypercalciuria and nephrocalcinosis
|
[NCBI]
|
0.000134448
|
|
|
BOR1
|
[NCBI]
|
0.000131481
|
|
|
PEE1
|
[NCBI]
|
0.000124499
|
|
|
muckle-wells syndrome
|
[NCBI]
|
0.000119112
|
|
|
denys-drash syndrome
|
[NCBI]
|
0.000119112
|
|
|
FGF23
|
[NCBI]
|
0.000112627
|
|
|
EPO
|
[NCBI]
|
0.000110251
|
|
|
KLK3
|
[NCBI]
|
0.000110092
|
|
|
RPGRIP1L
|
[NCBI]
|
0.000108888
|
|
|
tyrosinemia, type i
|
[NCBI]
|
9.81138e-05
|
|
|
FGA
|
[NCBI]
|
9.73902e-05
|
|
|
RA
|
[NCBI]
|
9.60333e-05
|
|
|
vasculopathy, retinal, with cerebral leukodystrophy
|
[NCBI]
|
9.45346e-05
|
|
|
hyperpipecolatemia
|
[NCBI]
|
8.96067e-05
|
|
|
CEACAM5
|
[NCBI]
|
8.93268e-05
|
|
|
MCKD2
|
[NCBI]
|
8.53615e-05
|
|
|
bartter syndrome, infantile, with sensorineural deafness
|
[NCBI]
|
8.53615e-05
|
|
|
SDC2
|
[NCBI]
|
8.23896e-05
|
|
|
FSGS3
|
[NCBI]
|
8.09225e-05
|
|
|
MKS5
|
[NCBI]
|
8.09225e-05
|
|
|
rod-cone dystrophy, sensorineural deafness, and fanconi-type renal dysfunction
|
[NCBI]
|
8.09225e-05
|
|
|
thrombocytopenia with elevated serum iga and renal disease
|
[NCBI]
|
8.09225e-05
|
|
|
hyperparathyroidism, neonatal self-limited primary, with hypercalciuria
|
[NCBI]
|
8.09225e-05
|
|
|
NPHP7
|
[NCBI]
|
8.09225e-05
|
|
|
COXPD5
|
[NCBI]
|
8.09225e-05
|
|
|
lymphedema-hypoparathyroidism syndrome
|
[NCBI]
|
8.09225e-05
|
|
|
vascular hyalinosis
|
[NCBI]
|
8.09225e-05
|
|
|
hypophosphatemia, renal, with intracerebral calcifications
|
[NCBI]
|
8.09225e-05
|
|
|
photomyoclonus, diabetes mellitus, deafness, nephropathy, and cerebral dysfunction
|
[NCBI]
|
8.09225e-05
|
|
|
ichthyosis, mental retardation, dwarfism, and renal impairment
|
[NCBI]
|
8.09225e-05
|
|
|
hypouricemia, renal
|
[NCBI]
|
7.83167e-05
|
|
|
BBS
|
[NCBI]
|
7.6107e-05
|
|
|
hyperprolinemia, type i
|
[NCBI]
|
7.26095e-05
|
|
|
BFH
|
[NCBI]
|
7.26095e-05
|
|
|
SLC22A6
|
[NCBI]
|
7.10895e-05
|
|
|
HOMG3
|
[NCBI]
|
7.01191e-05
|
|
|
VDR
|
[NCBI]
|
6.8704e-05
|
|
|
complement factor h deficiency
|
[NCBI]
|
6.56921e-05
|
|
|
dent disease 1
|
[NCBI]
|
6.56921e-05
|
|
|
coenzyme q10 deficiency
|
[NCBI]
|
6.56921e-05
|
|
|
bartter syndrome, antenatal, type 2
|
[NCBI]
|
6.56921e-05
|
|
|
AFP
|
[NCBI]
|
6.53591e-05
|
|
|
APRT
|
[NCBI]
|
6.48059e-05
|
|
|
CLDN16
|
[NCBI]
|
6.4417e-05
|
|
|
AVPR2
|
[NCBI]
|
6.37767e-05
|
|
|
PHA1
|
[NCBI]
|
6.3707e-05
|
|
|
AQP1
|
[NCBI]
|
6.29139e-05
|
|
|
SFRP4
|
[NCBI]
|
6.17878e-05
|
|
|
CSA
|
[NCBI]
|
6.14669e-05
|
|
|
immunoosseous dysplasia, schimke type
|
[NCBI]
|
6.01043e-05
|
|
|
deafness, cochlear, with myopia and intellectual impairment
|
[NCBI]
|
5.85603e-05
|
|
|
mullerian aplasia
|
[NCBI]
|
5.85603e-05
|
|
|
ulnar ray dysgenesis with postaxial polydactyly and renal cystic dysplasia
|
[NCBI]
|
5.85603e-05
|
|
|
FBS
|
[NCBI]
|
5.84599e-05
|
|
|
CEP290
|
[NCBI]
|
5.74158e-05
|
|
|
PDSS2
|
[NCBI]
|
5.44356e-05
|
|
|
GLIS2
|
[NCBI]
|
5.44356e-05
|
|
|
LBX2
|
[NCBI]
|
5.44356e-05
|
|
|
MUC20
|
[NCBI]
|
5.44356e-05
|
|
|
megsin
|
[NCBI]
|
5.44356e-05
|
|
|
SLC4A8
|
[NCBI]
|
5.44356e-05
|
|
|
glomerulocystic kidney disease with hyperuricemia and isosthenuria
|
[NCBI]
|
5.01885e-05
|
|
|
JBTS5
|
[NCBI]
|
5.01885e-05
|
|
|
hypouricemia, familial renal, due to tubular hypersecretion
|
[NCBI]
|
5.01885e-05
|
|
|
HOMG4
|
[NCBI]
|
5.01885e-05
|
|
|
CD2AP
|
[NCBI]
|
4.95441e-05
|
|
|
SLC12A3
|
[NCBI]
|
4.83008e-05
|
|
|
glycogen storage disease i
|
[NCBI]
|
4.77931e-05
|
|
|
NGFB
|
[NCBI]
|
4.5186e-05
|
|
|
glomerulonephritis with sparse hair and telangiectases
|
[NCBI]
|
4.47906e-05
|
|
|
coach syndrome
|
[NCBI]
|
4.47906e-05
|
|
|
PKDTS
|
[NCBI]
|
4.47906e-05
|
|
|
nephrotic syndrome, early-onset, with diffuse mesangial sclerosis
|
[NCBI]
|
4.47906e-05
|
|
|
RTADR
|
[NCBI]
|
4.0805e-05
|
|
|
osteolysis, hereditary multicentric
|
[NCBI]
|
4.0805e-05
|
|
|
GUCA2B
|
[NCBI]
|
4.06965e-05
|
|
|
TRPV5
|
[NCBI]
|
4.06965e-05
|
|
|
ACP2
|
[NCBI]
|
4.06965e-05
|
|
|
C1GALT1
|
[NCBI]
|
4.06965e-05
|
|
|
FCAS
|
[NCBI]
|
4.04068e-05
|
|
|
EGFR
|
[NCBI]
|
3.96998e-05
|
|
|
bartter syndrome, antenatal, type 1
|
[NCBI]
|
3.76513e-05
|
|
|
barraquer-simons syndrome
|
[NCBI]
|
3.76513e-05
|
|
|
UOX
|
[NCBI]
|
3.76513e-05
|
|
|
WT1
|
[NCBI]
|
3.58785e-05
|
|
|
SLC4A7
|
[NCBI]
|
3.55367e-05
|
|
|
COL15A1
|
[NCBI]
|
3.55367e-05
|
|
|
BDKRB1
|
[NCBI]
|
3.55367e-05
|
|
|
TGFA
|
[NCBI]
|
3.55367e-05
|
|
|
FCAR
|
[NCBI]
|
3.55367e-05
|
|
|
MALL
|
[NCBI]
|
3.55367e-05
|
|
|
MRPS22
|
[NCBI]
|
3.55367e-05
|
|
|
JUND
|
[NCBI]
|
3.55367e-05
|
|
|
MEFV
|
[NCBI]
|
3.5176e-05
|
|
|
GSN
|
[NCBI]
|
3.5176e-05
|
|
|
TNC
|
[NCBI]
|
3.50671e-05
|
|
|
nephrosialidosis
|
[NCBI]
|
3.50473e-05
|
|
|
donnai-barrow syndrome
|
[NCBI]
|
3.50473e-05
|
|
|
XRN
|
[NCBI]
|
3.50473e-05
|
|
|
ACE
|
[NCBI]
|
3.4959e-05
|
|
|
AGT
|
[NCBI]
|
3.46056e-05
|
|
|
GLA
|
[NCBI]
|
3.35186e-05
|
|
|
SLC2A2
|
[NCBI]
|
3.3e-05
|
|
|
JBTS3
|
[NCBI]
|
3.28339e-05
|
|
|
CRH
|
[NCBI]
|
3.26712e-05
|
|
|
TS
|
[NCBI]
|
3.25946e-05
|
|
|
NFAT5
|
[NCBI]
|
3.22006e-05
|
|
|
SLC22A12
|
[NCBI]
|
3.22006e-05
|
|
|
COQ2
|
[NCBI]
|
3.22006e-05
|
|
|
SLC4A4
|
[NCBI]
|
3.22006e-05
|
|
|
CLCNKA
|
[NCBI]
|
3.22006e-05
|
|
|
APCS
|
[NCBI]
|
3.10712e-05
|
|
|
HCA2
|
[NCBI]
|
3.09127e-05
|
|
|
whistling face syndrome, recessive form
|
[NCBI]
|
3.09127e-05
|
|
|
UGB
|
[NCBI]
|
2.97579e-05
|
|
|
ACTN4
|
[NCBI]
|
2.97305e-05
|
|
|
SMAD7
|
[NCBI]
|
2.97305e-05
|
|
|
DNASE1
|
[NCBI]
|
2.97305e-05
|
|
|
MATN1
|
[NCBI]
|
2.97305e-05
|
|
|
BDKRB2
|
[NCBI]
|
2.97305e-05
|
|
|
AQP9
|
[NCBI]
|
2.97305e-05
|
|
|
panencephalitis, subacute sclerosing
|
[NCBI]
|
2.94089e-05
|
|
|
pierson syndrome
|
[NCBI]
|
2.92182e-05
|
|
|
HES
|
[NCBI]
|
2.92182e-05
|
|
|
CALCRL
|
[NCBI]
|
2.89371e-05
|
|
|
BGLAP
|
[NCBI]
|
2.81391e-05
|
|
|
AGTR2
|
[NCBI]
|
2.77706e-05
|
|
|
NPHP4
|
[NCBI]
|
2.77706e-05
|
|
|
NPHS2
|
[NCBI]
|
2.77706e-05
|
|
|
epstein syndrome
|
[NCBI]
|
2.77048e-05
|
|
|
HHS
|
[NCBI]
|
2.77048e-05
|
|
|
gitelman syndrome
|
[NCBI]
|
2.77048e-05
|
|
|
HHRH
|
[NCBI]
|
2.77048e-05
|
|
|
liddle syndrome
|
[NCBI]
|
2.63395e-05
|
|
|
LAMB2
|
[NCBI]
|
2.61477e-05
|
|
|
CLCNKB
|
[NCBI]
|
2.61477e-05
|
|
|
GRHPR
|
[NCBI]
|
2.61477e-05
|
|
|
GPT
|
[NCBI]
|
2.60164e-05
|
|
|
HOMG
|
[NCBI]
|
2.50975e-05
|
|
|
B2M
|
[NCBI]
|
2.50464e-05
|
|
|
DNM2
|
[NCBI]
|
2.47644e-05
|
|
|
DAO
|
[NCBI]
|
2.47644e-05
|
|
|
AHI1
|
[NCBI]
|
2.47644e-05
|
|
|
AVP
|
[NCBI]
|
2.4274e-05
|
|
|
PLG
|
[NCBI]
|
2.40902e-05
|
|
|
hypertension, essential
|
[NCBI]
|
2.40343e-05
|
|
|
HSD17B4
|
[NCBI]
|
2.35602e-05
|
|
|
NPHP1
|
[NCBI]
|
2.35602e-05
|
|
|
d-bifunctional protein deficiency
|
[NCBI]
|
2.29112e-05
|
|
|
TREX1
|
[NCBI]
|
2.24951e-05
|
|
|
thrombocytopenic purpura, autoimmune
|
[NCBI]
|
2.24035e-05
|
|
|
FRAP1
|
[NCBI]
|
2.22838e-05
|
|
|
renal tubular acidosis, distal, autosomal dominant
|
[NCBI]
|
2.19401e-05
|
|
|
NPY
|
[NCBI]
|
2.17797e-05
|
|
|
INVS
|
[NCBI]
|
2.1541e-05
|
|
|
phosphoribosylpyrophosphate synthetase superactivity
|
[NCBI]
|
2.10367e-05
|
|
|
CFTR
|
[NCBI]
|
2.10122e-05
|
|
|
GATA3
|
[NCBI]
|
2.06777e-05
|
|
|
CCK
|
[NCBI]
|
2.04856e-05
|
|
|
amyloidosis v
|
[NCBI]
|
2.0193e-05
|
|
|
cirrhosis, familial
|
[NCBI]
|
2.0193e-05
|
|
|
DRRS
|
[NCBI]
|
2.0193e-05
|
|
|
KSS
|
[NCBI]
|
2.00023e-05
|
|
|
LMX1B
|
[NCBI]
|
1.989e-05
|
|
|
SAA1
|
[NCBI]
|
1.989e-05
|
|
|
HRPT2
|
[NCBI]
|
1.94024e-05
|
|
|
NPPA
|
[NCBI]
|
1.92906e-05
|
|
|
CAV1
|
[NCBI]
|
1.91663e-05
|
|
|
TG
|
[NCBI]
|
1.91139e-05
|
|
|
hartnup disorder
|
[NCBI]
|
1.86592e-05
|
|
|
PHA2
|
[NCBI]
|
1.86592e-05
|
|
|
TTR
|
[NCBI]
|
1.85782e-05
|
|
|
RTD
|
[NCBI]
|
1.79587e-05
|
|
|
HP
|
[NCBI]
|
1.77087e-05
|
|
|
APOE
|
[NCBI]
|
1.73169e-05
|
|
|
CTNS
|
[NCBI]
|
1.72957e-05
|
|
|
KL
|
[NCBI]
|
1.72957e-05
|
|
|
CFB
|
[NCBI]
|
1.67523e-05
|
|
|
methylmalonic aciduria and homocystinuria, cblc type
|
[NCBI]
|
1.66703e-05
|
|
|
GACI
|
[NCBI]
|
1.66703e-05
|
|
|
temporal arteritis
|
[NCBI]
|
1.65203e-05
|
|
|
PTPRC
|
[NCBI]
|
1.62414e-05
|
|
|
udp-n-acetylglucosamine 2-epimerase/n-acetylmannosamine kinase
|
[NCBI]
|
1.62414e-05
|
|
|
acyl-coa dehydrogenase, medium-chain, deficiency of
|
[NCBI]
|
1.60757e-05
|
|
|
WHS
|
[NCBI]
|
1.58483e-05
|
|
|
CFH
|
[NCBI]
|
1.583e-05
|
|
|
MYH9
|
[NCBI]
|
1.53041e-05
|
|
|
ILK
|
[NCBI]
|
1.51931e-05
|
|
|
GAS
|
[NCBI]
|
1.48722e-05
|
|
|
CTSL
|
[NCBI]
|
1.48722e-05
|
|
|
ALMS
|
[NCBI]
|
1.44591e-05
|
|
|
refsum disease, infantile form
|
[NCBI]
|
1.44591e-05
|
|
|
IFNG
|
[NCBI]
|
1.40712e-05
|
|
|
MHA
|
[NCBI]
|
1.39689e-05
|
|
|
lecithin:cholesterol acyltransferase deficiency
|
[NCBI]
|
1.39689e-05
|
|
|
mitochondrial complex i deficiency
|
[NCBI]
|
1.39689e-05
|
|
|
LCAT
|
[NCBI]
|
1.34867e-05
|
|
|
ABP1
|
[NCBI]
|
1.34605e-05
|
|
|
PKD1
|
[NCBI]
|
1.31949e-05
|
|
|
RNASE3
|
[NCBI]
|
1.31067e-05
|
|
|
SOD2
|
[NCBI]
|
1.30134e-05
|
|
|
ENPEP
|
[NCBI]
|
1.30017e-05
|
|
|
LCA1
|
[NCBI]
|
1.26216e-05
|
|
|
CASR
|
[NCBI]
|
1.24335e-05
|
|
|
MADD
|
[NCBI]
|
1.2209e-05
|
|
|
gm1-gangliosidosis, type i
|
[NCBI]
|
1.18128e-05
|
|
|
LPL
|
[NCBI]
|
1.18054e-05
|
|
|
JAG1
|
[NCBI]
|
1.17708e-05
|
|
|
GAMT
|
[NCBI]
|
1.14917e-05
|
|
|
glycogen storage disease ixa
|
[NCBI]
|
1.12227e-05
|
|
|
XDH
|
[NCBI]
|
1.10875e-05
|
|
|
hyperoxaluria, primary, type i
|
[NCBI]
|
1.10655e-05
|
|
|
PI
|
[NCBI]
|
1.08853e-05
|
|
|
mitochondrial complex iv deficiency
|
[NCBI]
|
1.07127e-05
|
|
|
BWS
|
[NCBI]
|
1.05237e-05
|
|
|
FIH
|
[NCBI]
|
1.03728e-05
|
|
|
periodic fever, familial, autosomal dominant
|
[NCBI]
|
1.03728e-05
|
|
|
MODY
|
[NCBI]
|
1.00375e-05
|
|
|
MUC1
|
[NCBI]
|
9.92348e-06
|
|
|
TSC1
|
[NCBI]
|
8.97255e-06
|
|
|
SPP1
|
[NCBI]
|
8.95914e-06
|
|
|
SPINK1
|
[NCBI]
|
8.92569e-06
|
|
|
wolman disease
|
[NCBI]
|
8.78303e-06
|
|
|
VHL
|
[NCBI]
|
8.62171e-06
|
|
|
ATS
|
[NCBI]
|
8.56821e-06
|
|
|
PXE
|
[NCBI]
|
8.50687e-06
|
|
|
AQP2
|
[NCBI]
|
7.90979e-06
|
|
|
APOA1
|
[NCBI]
|
7.43819e-06
|
|
|
HSAN3
|
[NCBI]
|
7.31734e-06
|
|
|
TGFB1
|
[NCBI]
|
7.1428e-06
|
|
|
CCL2
|
[NCBI]
|
7.00038e-06
|
|
|
PKD2
|
[NCBI]
|
6.86131e-06
|
|
|
PCNA
|
[NCBI]
|
6.47543e-06
|
|
|
HNF1A
|
[NCBI]
|
6.3362e-06
|
|
|
adrenoleukodystrophy, autosomal neonatal form
|
[NCBI]
|
6.24715e-06
|
|
|
HBB
|
[NCBI]
|
6.17565e-06
|
|
|
PTN
|
[NCBI]
|
6.09091e-06
|
|
|
ED1
|
[NCBI]
|
6.05173e-06
|
|
|
SCA7
|
[NCBI]
|
5.49866e-06
|
|
|
sickle cell anemia
|
[NCBI]
|
5.49866e-06
|
|
|
aHUS
|
[NCBI]
|
5.49866e-06
|
|
|
TSC2
|
[NCBI]
|
5.2087e-06
|
|
|
MKS1
|
[NCBI]
|
4.99136e-06
|
|
|
ARPKD
|
[NCBI]
|
4.83164e-06
|
|
|
MCP
|
[NCBI]
|
4.20663e-06
|
|
|
TNF
|
[NCBI]
|
4.16846e-06
|
|
|
STAR
|
[NCBI]
|
4.12559e-06
|
|
|
PTHLH
|
[NCBI]
|
3.66355e-06
|
|
|
velocardiofacial syndrome
|
[NCBI]
|
3.57772e-06
|
|
|
TYMS
|
[NCBI]
|
3.54229e-06
|
|
|
TNFRSF11B
|
[NCBI]
|
3.32679e-06
|
|
|
PG
|
[NCBI]
|
3.19634e-06
|
|
|
WAS
|
[NCBI]
|
2.93011e-06
|
|
|
LAM
|
[NCBI]
|
2.90872e-06
|
|
|
PTK2
|
[NCBI]
|
2.81256e-06
|
|
|
LPI
|
[NCBI]
|
2.79545e-06
|
|
|
CDK5
|
[NCBI]
|
2.61335e-06
|
|
|
ALD
|
[NCBI]
|
2.54885e-06
|
|
|
SLS
|
[NCBI]
|
2.4112e-06
|
|
|
AGER
|
[NCBI]
|
1.48879e-06
|
|
|
PTEN
|
[NCBI]
|
1.35548e-06
|
|
|
COMT
|
[NCBI]
|
1.14748e-06
|
|
|
PF4
|
[NCBI]
|
8.62228e-07
|
|
|
VEGF
|
[NCBI]
|
7.70525e-07
|
|
|
F3
|
[NCBI]
|
6.11059e-07
|
|
|
GAPDH
|
[NCBI]
|
5.7442e-07
|
|
|
leber optic atrophy
|
[NCBI]
|
4.87208e-07
|
|
|
CVID
|
[NCBI]
|
4.06134e-07
|
|
|
CDLS1
|
[NCBI]
|
3.97721e-07
|
|
|
EGF
|
[NCBI]
|
3.42928e-07
|
|
|
MAS
|
[NCBI]
|
2.92635e-07
|
|
|
PPARA
|
[NCBI]
|
2.63061e-07
|
|
|
ADA
|
[NCBI]
|
2.48027e-07
|
|
|
ALK
|
[NCBI]
|
6.24879e-08
|
|
|
hla-d histocompatibility type
|
[NCBI]
|
6.24879e-08
|
|
|
EIG
|
[NCBI]
|
2.27488e-08
|
|
|
MBL2
|
[NCBI]
|
1.47602e-10
|
|